Rajesh Chavan

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Staphylococcus Aureus

Helicobacter Pylori

Silver Nanoparticles

Top Venues

Xenobiotica; the fate of foreign compounds in biological systems

Microbial drug resistance (Larchmont, N.Y.)

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Rajesh Chavan, Bhushan Naphade, Bhalchandra Waykar, Sachin Bhagwat
Investigations on In Vivo Pharmacokinetic/Pharmacodynamic Determinants of Fosfomycin in Murine Thigh and Kidney Infection Models. Microbial drug resistance (Larchmont, N.Y.) (2022)
Rajesh Chavan, Vineet Zope, Nilesh Chavan, Javeed Shaikh, Kiran R Patil, Ravindra Yeole, Sachin S Bhagwat, Mahesh Patel
Assessment of in vitro inhibitory effects of novel anti MRSA benzoquinolizine fluoroquinolone WCK 771 (levonadifloxacin) and its metabolite on human liver cytochrome P450 enzymes. Xenobiotica; the fate of foreign compounds in biological systems 50 (10) (2020)
Rajesh Chavan, Vineet Zope, Nilesh Chavan, Kiran R Patil, Ravindra Yeole, Sachin S Bhagwat, Mahesh Patel
Assessment of the in vitro cytochrome P450 (CYP) inhibition potential of nafithromycin, a next generation lactone ketolide antibiotic. Xenobiotica; the fate of foreign compounds in biological systems 51 (3) (2020)
Sachin S Bhagwat, Manohar Nandanwar, Atul Kansagara, Anusuya Patel, Swapna Takalkar, Rajesh Chavan, Hariharan Periasamy, Ravindra Yeole, Prasad K Deshpande, Satish Bhavsar, Ashima Bhatia, Jaishid Ahdal, Rishi Jain, Mahesh Patel
Levonadifloxacin, a Novel Broad-Spectrum Anti-MRSA Benzoquinolizine Quinolone Agent: Review of Current Evidence. Drug design, development and therapy 13 (2019)